← Back to Search

Accessible Hearing Care Interventions for Hearing Loss

N/A
Recruiting
Led By Marcia J Hay-McCutcheon, PhD
Research Sponsored by University of Alabama, Tuscaloosa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
40 years of age or older
Be older than 18 years old
Must not have
Medical conditions resulting in severe cognitive impairment (e.g., stroke, head injury, senile dementia or Alzheimer's disease)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up a baseline outcome will be obtained prior to over-the-counter hearing aid fitting. outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how well three different interventions work to improve quality of care for adults with mild-to-moderate hearing loss who don't have access to hearing healthcare.

Who is the study for?
This trial is for adults over 40 living in West Central or South Alabama who have mild-to-moderate hearing loss. It's not open to those with severe cognitive impairments from conditions like stroke, head injury, dementia, or Alzheimer's disease.
What is being tested?
The study tests three interventions: providing personal sound amplification products (PSAPs), a four-week aural rehabilitation program, and PSAP fitting/orientation alongside regular hearing evaluations to improve hearing healthcare access and affordability.
What are the potential side effects?
There are generally no significant side effects expected from the interventions being tested as they involve non-invasive measures such as using PSAPs and participating in rehabilitation programs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have severe cognitive issues from conditions like stroke or Alzheimer's.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~a baseline outcome will be obtained prior to over-the-counter hearing aid fitting. outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and a baseline outcome will be obtained prior to over-the-counter hearing aid fitting. outcomes will be measured at weeks 4 to 7 of intervention, during week 14 of the intervention, and through study completion, or 1 assessment each year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measuring Change in International Outcome Inventory for Hearing Aids (IOI-HA) Outcomes
Measuring Change in the Hearing Handicap Inventory for Elderly (HHIE) Outcomes
Secondary study objectives
Measuring Change in Northwestern University-6 (NU-6) Word Recognition Outcomes
Measuring Change in Quick Speech In Noise (SIN) Word Recognition Outcomes
Measuring Change in the Abbreviated Profile of Hearing Aid Benefit (APHAB)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Audiology Best Practices plus Aural Rehabilitation (ABP+AR)Experimental Treatment3 Interventions
This experimental group will receive a hearing evaluation, an over-the-counter hearing aid fitting and orientation, and four-weeks of an aural rehabilitation program conducted by specially-trained community health workers. Additionally, these adults will complete pre- and post-questionnaires and speech perception testing.
Group II: Over-the-Counter Only (OTC-Only)Active Control2 Interventions
This comparison group of adults with hearing loss will receive a hearing evaluation. They will be provided with over-the-counter hearing aids but the audiologist will not assist with fitting the aids or providing an orientation. This arm mimics what would happen when a consumer privately purchases over-the-counter hearing aids. They will complete pre- and post-questionnaires and speech perception testing.
Group III: Audiology Best Practices (ABP)Active Control2 Interventions
This comparison group of adults with hearing loss will receive a hearing evaluation and over-the-counter hearing aid fitting and orientation. The aural rehabilitation program will not be provided initially. These participants will complete pre- and post-questionnaires and speech perception testing.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamOTHER
1,646 Previous Clinical Trials
2,342,563 Total Patients Enrolled
University of Alabama, TuscaloosaLead Sponsor
46 Previous Clinical Trials
17,368 Total Patients Enrolled
Marcia J Hay-McCutcheon, PhDPrincipal InvestigatorThe University of Alabama, Tuscaloosa

Media Library

Hearing Evaluation Clinical Trial Eligibility Overview. Trial Name: NCT04671381 — N/A
Hearing Loss Research Study Groups: Over-the-Counter Only (OTC-Only), Audiology Best Practices (ABP), Audiology Best Practices plus Aural Rehabilitation (ABP+AR)
Hearing Loss Clinical Trial 2023: Hearing Evaluation Highlights & Side Effects. Trial Name: NCT04671381 — N/A
Hearing Evaluation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04671381 — N/A
~43 spots leftby Dec 2025